Kyntra Bio (KYNB) Total Debt (2023 - 2026)
Kyntra Bio (KYNB) posted Total Debt of $73.7 million for Q2 2025, little changed sequentially from $73.4 million in Q1 2025, and up 1.73% YoY from $72.5 million in Q2 2024.
Kyntra Bio (KYNB) Total Debt (2023 - 2026) Analysis & Trends
Kyntra Bio has reported Total Debt for 3 years, with the latest figure at $73.7 million in Q2 2025.
- Quarterly Total Debt rose 1.73% year-over-year to $73.7 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $73.7 million (up 1.73% YoY) and the FY2024 annual result came in at $73.1 million, up 1.61% from the prior year.
- Total Debt was little changed at $73.7 million in Q2 2025 per KYNB's latest filing, from $73.4 million in the prior quarter.
- Over five years, Total Debt peaked at $73.7 million in Q2 2025 and troughed at $71.4 million in Q2 2023.
- A 3-year average of $72.5 million and a median of $72.5 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2025: Total Debt advanced 1.5% in 2024, then grew 1.73% in 2025.
- Over 3 years, Total Debt stood at $71.9 million in 2023, then climbed by 1.61% to $73.1 million in 2024, then grew by 0.88% to $73.7 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $73.7 million, $73.4 million, and $73.1 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 9.34 Bn |
| 10 | Kyntra Bio | 30.40 Mn | 30.40 Mn | 1.47 Mn | 19.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.20 Mn |
| Jun 30, 2025 | 73.73 Mn |
| Mar 31, 2025 | 73.42 Mn |
| Dec 31, 2024 | 73.09 Mn |
| Sep 30, 2024 | 72.78 Mn |
| Jun 30, 2024 | 72.48 Mn |
| Mar 31, 2024 | 72.21 Mn |
| Dec 31, 2023 | 71.93 Mn |
| Sep 30, 2023 | 71.67 Mn |
| Jun 30, 2023 | 71.41 Mn |